Dashboard
Manage Tickers

CRBP Corbus Pharmaceuticals Hold...

Nasdaq corbuspharma.com


$ 11.56 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 06:47:11 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 619.81 $ 0.00 (0 %)
DIA $ 482.03 $ 0.00 (0 %)
SPY $ 681.88 $ 0.00 (0 %)
TLT $ 89.82 $ 0.00 (0 %)
GLD $ 389.72 $ 0.00 (0 %)
$ 11.19
$ 10.35
$ 11.19 x 1
$ 11.49 x 9
-- - --
$ 4.64 - $ 20.56
463,183
na
196.42M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-12-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-07-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-08-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-15-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-16-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-12-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-08-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-28-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

corbus-pharmaceuticals-q3-eps-190-misses-172-estimate
Corbus Pharmaceuticals Q3 EPS $(1.90) Miss...
11/12/2025 13:08:39

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.90) per share which missed the analyst consensus estimate...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/31/2025 17:06:11

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/31/2025 12:10:20

roku-sps-commerce-newell-brands-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Roku, SPS Commerce, Newell Brands And Othe...
10/31/2025 12:09:18

why-amazon-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket
Why Amazon Shares Are Trading Higher By Ov...
10/31/2025 09:31:59

corbus-pharmaceuticals-prices-75m-public-offering-of-4744231-common-stock-and-pre-funded-warrants-at-1300-per-share-to-advance-oncology-and-obesity-pipeline
Corbus Pharmaceuticals Prices $75M Public ...
10/31/2025 07:10:28

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 21:07:13

corbus-pharmaceuticals-announces-proposed-public-offering-size-not-given
Corbus Pharmaceuticals Announces Proposed ...
10/30/2025 20:37:39

wedbush-maintains-outperform-on-corbus-pharmaceuticals-raises-price-target-to-38
Wedbush Maintains Outperform on Corbus Pha...
10/20/2025 13:16:48

Wedbush analyst Robert Driscoll maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and raises the price target...

hc-wainwright--co-reiterates-buy-on-corbus-pharmaceuticals-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Corb...
10/20/2025 11:44:33

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains...

reported-saturday-corbus-pharmaceuticals-presents-crb-701-data-at-european-society-for-medical-oncology-2025-showing-476-objective-response-rate-in-head-and-neck-squamous-cell-carcinoma-375-in-cervical-cancer-and-556-in-urothelial-tumors
Reported Saturday, Corbus Pharmaceuticals ...
10/20/2025 08:25:04

3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a fav...

corbus-pharmaceuticals-releases-abstract-for-its-phase-12-oncology-study-ahead-of-presentation-at-esmo-congress-2025-abstract-includes-safety-data-from-70-participants
Corbus Pharmaceuticals Releases Abstract F...
10/14/2025 12:07:06

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical stage company focused on oncology and obesity, announced today t...

hc-wainwright--co-reiterates-buy-on-corbus-pharmaceuticals-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Corb...
09/17/2025 10:26:46

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains...

fda-grants-fast-track-designation-to-corbus-pharmaceuticals-nectin-4-for-head-and-neck-squamous-cell-carcinoma
FDA Grants Fast Track Designation To Corbu...
09/16/2025 12:01:48

oppenheimer-maintains-outperform-on-corbus-pharmaceuticals-lowers-price-target-to-53
Oppenheimer Maintains Outperform on Corbus...
08/06/2025 12:11:40

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and lowers the price target ...

corbus-pharmaceuticals-q2-eps-144-beats-152-estimate
Corbus Pharmaceuticals Q2 EPS $(1.44) Beat...
08/05/2025 12:36:43

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.44) per share which beat the analyst consensus estimate o...

corbus-pharmaceuticals-announces-that-an-abstract-on-updated-clinical-data-from-its-phase-12-clinical-study-of-crb-701-has-been-accepted-for-presentation-as-a-poster-at-the-european-society-for-medical-oncology--congress-2025--october-17-21-2025-in-berlin-germany
Corbus Pharmaceuticals Announces That An A...
07/30/2025 12:02:27

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, announced today t...

Core News & Articles
Cannabis Stock Gainers And Losers From Jul...
07/16/2025 20:32:21

Core News & Articles
Cannabis Stock Movers For July 15, 2025
07/15/2025 20:30:09

Core News & Articles
Bullish Sentiment Across The Cannabis Spac...
07/09/2025 20:30:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION